|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
99.60%
|
97.25%
|
|
CHEMBL3837
|
P07711
|
Cathepsin L |
99.49%
|
96.61%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.26%
|
98.95%
|
|
CHEMBL299
|
P17252
|
Protein kinase C alpha |
99.07%
|
98.03%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
99.04%
|
94.45%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
98.97%
|
96.09%
|
|
CHEMBL2955
|
O95136
|
Sphingosine 1-phosphate receptor Edg-5 |
98.88%
|
92.86%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
97.88%
|
93.56%
|
|
CHEMBL4793
|
Q86TI2
|
Dipeptidyl peptidase IX |
97.78%
|
96.95%
|
|
CHEMBL4026
|
P40763
|
Signal transducer and activator of transcription 3 |
97.62%
|
82.69%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
97.42%
|
98.94%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
97.01%
|
97.21%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
96.97%
|
98.33%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
96.81%
|
94.66%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
96.53%
|
100.00%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
96.37%
|
96.47%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
96.26%
|
97.47%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
96.14%
|
90.17%
|
|
CHEMBL3892
|
Q99500
|
Sphingosine 1-phosphate receptor Edg-3 |
96.10%
|
97.29%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
96.08%
|
95.71%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
96.06%
|
99.17%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
95.88%
|
92.38%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
95.72%
|
100.00%
|
|
CHEMBL2996
|
Q05655
|
Protein kinase C delta |
95.27%
|
97.79%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
94.87%
|
97.23%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
94.45%
|
97.50%
|
|
CHEMBL2815
|
P04629
|
Nerve growth factor receptor Trk-A |
94.10%
|
87.16%
|
|
CHEMBL3776
|
Q14790
|
Caspase-8 |
93.60%
|
97.06%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
93.30%
|
97.29%
|
|
CHEMBL4462
|
Q8IXJ6
|
NAD-dependent deacetylase sirtuin 2 |
93.07%
|
90.24%
|
|
CHEMBL4506
|
Q96EB6
|
NAD-dependent deacetylase sirtuin 1 |
92.97%
|
88.33%
|
|
CHEMBL335
|
P18031
|
Protein-tyrosine phosphatase 1B |
92.93%
|
95.17%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
92.78%
|
90.71%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
92.49%
|
96.85%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
92.05%
|
100.00%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
92.03%
|
100.00%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
91.91%
|
94.00%
|
|
CHEMBL5979
|
P05186
|
Alkaline phosphatase, tissue-nonspecific isozyme |
91.01%
|
85.40%
|
|
CHEMBL4662
|
P28074
|
Proteasome Macropain subunit MB1 |
90.89%
|
93.85%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
90.87%
|
97.09%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
90.11%
|
97.14%
|
|
CHEMBL3238
|
P23786
|
Carnitine palmitoyltransferase 2 |
90.03%
|
94.05%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
89.82%
|
91.19%
|
|
CHEMBL1907605
|
P24864
|
Cyclin-dependent kinase 2/cyclin E1 |
89.67%
|
92.88%
|
|
CHEMBL332
|
P03956
|
Matrix metalloproteinase-1 |
89.39%
|
94.50%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
89.17%
|
91.81%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
88.92%
|
97.50%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
88.68%
|
96.28%
|
|
CHEMBL5163
|
Q9NY46
|
Sodium channel protein type III alpha subunit |
88.56%
|
96.90%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
88.42%
|
94.33%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
88.41%
|
93.00%
|
|
CHEMBL3145
|
P42338
|
PI3-kinase p110-beta subunit |
88.34%
|
98.75%
|
|
CHEMBL1744525
|
P43490
|
Nicotinamide phosphoribosyltransferase |
88.26%
|
96.25%
|
|
CHEMBL230
|
P35354
|
Cyclooxygenase-2 |
86.95%
|
89.63%
|
|
CHEMBL5608
|
Q16288
|
NT-3 growth factor receptor |
86.43%
|
95.89%
|
|
CHEMBL268
|
P43235
|
Cathepsin K |
86.13%
|
96.85%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
85.98%
|
96.67%
|
|
CHEMBL4581
|
P52732
|
Kinesin-like protein 1 |
85.86%
|
93.18%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
85.64%
|
97.64%
|
|
CHEMBL1293267
|
Q9HC97
|
G-protein coupled receptor 35 |
85.17%
|
89.34%
|
|
CHEMBL4073
|
P09237
|
Matrix metalloproteinase 7 |
85.08%
|
97.56%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
85.07%
|
97.50%
|
|
CHEMBL3230
|
O95977
|
Sphingosine 1-phosphate receptor Edg-6 |
84.87%
|
94.01%
|
|
CHEMBL3018
|
Q9Y5Y6
|
Matriptase |
84.19%
|
98.33%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
84.14%
|
88.42%
|
|
CHEMBL2007625
|
O75874
|
Isocitrate dehydrogenase [NADP] cytoplasmic |
84.01%
|
99.00%
|
|
CHEMBL4769
|
O95749
|
Geranylgeranyl pyrophosphate synthetase |
83.42%
|
92.08%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
82.90%
|
96.03%
|
|
CHEMBL2001
|
Q9H244
|
Purinergic receptor P2Y12 |
82.79%
|
96.00%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
82.56%
|
96.00%
|
|
CHEMBL4015
|
P41597
|
C-C chemokine receptor type 2 |
82.32%
|
98.57%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
81.86%
|
91.11%
|
|
CHEMBL3024
|
P53350
|
Serine/threonine-protein kinase PLK1 |
81.83%
|
97.43%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
81.62%
|
98.24%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
81.60%
|
89.50%
|
|
CHEMBL2431
|
P31751
|
Serine/threonine-protein kinase AKT2 |
81.36%
|
98.33%
|
|
CHEMBL2208
|
P49137
|
MAP kinase-activated protein kinase 2 |
80.50%
|
95.20%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
80.35%
|
95.89%
|
|
CHEMBL1968
|
P07099
|
Epoxide hydrolase 1 |
80.31%
|
98.57%
|